University of Bristol: Lead Academic in Discussion with Industry to Apply New Nanoparticle Technology

The University of Bristol uses IN-PART to not only increase the exposure of their latest research to a global network of verified R&D professionals, but to also enhance their renowned reputation as an institution committed to industry partnerships and the commercialisation of university research. Frances Frith, Business Account and KTP Manager, shared with us her thoughts on IN-PART:

We’ve used IN-PART to promote a variety of technologies, ranging from novel materials coatings and power-converters, to new vaccine delivery systems and medical devices. Several companies have contacted us in a short space of time of using IN-PART, and one technology in particular relating to nanoparticles received significant interest, resulting in a senior member of a multinational medical equipment company contacting us, interested in commercialising the technology. Our academic has now met and had positive discussions with the company, and an NDA is currently being put in place with a view to a potential collaboration.”

“Having a unique system that not only provides insight into the impact of our technologies on industry, but also provides a reliable point of contact and access to senior level decision makers, means IN-PART has been an asset to the team here at Bristol.”

Read more case studies of collaborations that started through IN-PART’s matchmaking platform for university-industry collaboration.

Copyrights reserved unless otherwise agreed – IN-PART Publishing Ltd., 2018

Collaboration Case Study University of Bristol - IN-PART - Blog Header_1.0

Working in a company?

Gain a competitive advantage by identifying cutting-edge innovation and expertise from universities and institutes worldwide.

Get started

Are you an academic?

Advance research, generate impact and secure funding by partnering with industry teams around the world.

Get started

Part of a university?

Engage with industry teams from all sectors looking for a wide range of opportunities from early-stage to late-stage research, technologies, spin-outs and expertise for consultancy.

Request a demo